logo

For the Inventor, By the Inventor

Atlanta, GA, United States of America

Harry Hebblewhite

USPTO Granted Patents = 42 


 

Average Co-Inventor Count = 2.1

ph-index = 5

Forward Citations = 120(Granted Patents)


Company Filing History:

goldMedal40 out of 54 
 
Aseko, Inc.
 patents
silverMedal1 out of 1 
 
Glytec, LLC
 patent
bronzeMedal1 out of 832,891 
Other
 patents

Years Active: 2016-2025

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Insulin Management
Diabetes Medications
Diabetes Management
Subcutaneous Outpatient Management
Insulin Bolus Management
Insulin Infusion Rate Management
Insulin Dosing Controller
Diabetes Therapy Advisor
Insulin Administration
Carbohydrate-to-Insulin Ratios
Patient Care Technology
Chronic Disease Management
42 patents (USPTO):Explore Patents
1. 12288620 - Method and system for insulin management (2025-04-29),
2. 12205698 - Advising diabetes medications (2025-01-21),
3. 12127831 - Insulin management (2024-10-29),
4. 12040096 - Diabetes management therapy advisor (2024-07-16),
5. 12027266 - Insulin management (2024-07-02),
6. 12023127 - Subcutaneous outpatient management (2024-07-02),
7. 11908561 - Advising diabetes medications (2024-02-20),
8. 11857314 - Insulin management (2024-01-02),
9. 11804300 - Insulin management (2023-10-31),
10. 11783946 - Method and system for insulin bolus management (2023-10-10),
11. 11783945 - Method and system for insulin infusion rate management (2023-10-10),
12. 11728022 - Advising diabetes medications (2023-08-15),
13. 11694785 - Method and dosing controller for subcutaneous outpatient management (2023-07-04),
14. 11678800 - Subcutaneous outpatient management (2023-06-20),
15. 11621074 - Insulin management (2023-04-04),

As an AI assistant for idiyas.com, specializing in innovations, inventions, inventors, patent attorneys, assignees, and patents, I can provide you with the requested article about inventor Harry Hebblewhite based on the given data. Here is the structured article:

Title: Unveiling the Inventive Mind of Harry Hebblewhite

Introduction:

Innovator extraordinaire Harry Hebblewhite, based in Atlanta, GA (US), is a prolific inventor with an impressive portfolio of 39 patents to his name. His groundbreaking work in the field of diabetes management therapy has revolutionized the way insulin is administered and managed, showcasing his dedication to improving healthcare outcomes for patients worldwide.

Latest Patents:

Among his recent patents is the 'Diabetes Management Therapy Advisor,' a cutting-edge method that involves utilizing patient data to identify optimum treatment doses of insulin tailored to individual patient needs. Additionally, his 'Insulin Management' patent demonstrates his innovative approach to administering insulin based on real-time patient glucose measurements and personalized treatment plans.

Career Highlights:

Throughout his illustrious career, Harry Hebblewhite has made significant contributions to the medical field, particularly in diabetes management. His inventive spirit and commitment to enhancing patient care have earned him recognition as a trailblazer in the healthcare technology industry.

Collaborations:

Harry Hebblewhite has collaborated with esteemed professionals in the industry, including Robert C. Booth and Andrew Rhinehart. Together, they have worked on various projects that have led to groundbreaking advancements in diabetes treatment and management, solidifying their status as thought leaders in the field.

Conclusion:

In conclusion, Harry Hebblewhite's passion for innovation and his relentless pursuit of excellence have cemented his legacy as a visionary inventor in the healthcare technology sector. His patents continue to inspire future generations of inventors to push the boundaries of what is possible in the quest for improved patient care and medical advancements.

If you require more information or have any further requests regarding inventors, innovations, or patents, feel free to let me know!

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…